{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-282236","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2023-11-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.506693+00:00","generated_at":"2026-06-07T22:20:20.783410+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"President Leonid Beigelman resigns; severance includes 6 months salary, 12 months COBRA","bullets":["Dr. Leonid Beigelman, President, resigned effective Nov 20, 2023; entered into separation agreement.","Separation agreement includes general release of claims and standard restrictive covenants.","Severance includes 6 months of current base salary and COBRA continuation at company expense for 12 months.","Agreement to be filed as exhibit to 2023 Form 10-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-282236","json":"https://secwatch.observer/filing/0001193125-23-282236.json","markdown":"https://secwatch.observer/filing/0001193125-23-282236.md","text":"https://secwatch.observer/filing/0001193125-23-282236.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312523282236/0001193125-23-282236-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312523282236/d589765d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T22:20:20.783410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4bd9ea603c","claim":"Leonid Beigelman resigned as President at Aligos Therapeutics, Inc..","evidence_excerpt":"On November 20, 2023, in connection with the previously disclosed resignation of Leonid Beigelman, President of Aligos Therapeutics, Inc. (the “Company”), the Company and Dr. Beigelman entered into a separation and release agreement","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799448/000119312523282236/0001193125-23-282236-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}